PD Dr. Friedrich Hahn

Medizinische Fakultät Institute of Clinical and Molecular Virology Professur für Virologie

Facile Synthesis of New Antiviral Fluoro-Quinazolines Enabled by Merging Domino Reactions (2025) Kohlbauer S, Xia H, Grau B, Wangen C, Hahn F, Nenajdenko VG, Marschall M, Tsogoeva S Journal article Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity (2024) Herrmann A, Gege C, Wangen C, Wagner S, Kögler M, Cordsmeier A, Irrgang P, et al. Journal article Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity (2024) Gege C, Hahn F, Wangen C, Häge S, Herrmann A, Uhlig N, Eberlein V, et al. Journal article A domino reaction strategy for facile and modular construction of synthetically challenging functionalized ortho-fluoroanilines (2024) Grau B, Kohlbauer S, Gu YG, Hahn F, Lösing J, Wangen C, Stangier M, et al. Journal article Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies (2024) Obergfäll D, Wild M, Sommerer M, Barillas Dahm M, Kicuntod J, Tillmanns J, Kögler M, et al. Journal article Establishment of a Luciferase-Based Reporter System to Study Aspects of Human Cytomegalovirus Infection, Replication Characteristics, and Antiviral Drug Efficacy (2024) Tillmanns J, Kicuntod J, Ehring A, Elbasani E, Borst EM, Obergfäll D, Müller R, et al. Journal article Validation of nuclear receptor RORγ isoform 1 as a novel host-directed antiviral target based on the modulation of cholesterol levels (2024) Wangen C, Raithel A, Tillmanns J, Gege C, Herrmann A, Vitt D, Kohlhof H, et al. Journal article Autofluorescent Artemisinin-Benzimidazole Hybrids via Organo-Click Reaction: Study of Antiviral Properties and Mode of Action in Living Cells (2023) Herrmann L, Hahn F, Grau B, Wild M, Niesar A, Wangen C, Kataev E, et al. Journal article Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target (2023) Tillmanns J, Häge S, Borst EM, Wardin J, Eickhoff J, Klebl B, Wagner S, et al. Journal article The Trimeric Artesunate Analog TF27, a Broadly Acting Anti-Infective Model Drug, Exerts Pronounced Anti-SARS-CoV-2 Activity Spanning Variants and Host Cell Types (2023) Hahn F, Wangen C, Häge S, Herrmann L, Herrmann A, Tsogoeva S, Marschall M Journal article